A post-doctoral position and a PhD position are open to study structure, mechanism and function of clinically relevant cation/proton antiporters and their integration in signalling processes. The project is part of the Collaborative Research Center 746 (http://www.sfb746.uni-freiburg.de) and is connected to the European Drug Initiative on Channels and Transporters (http://www.edict-project.eu). The Hunte research group is based at the Institute for Biochemistry and Molecular Biology of the University of Freiburg and is member of the BIOSS Centre for Biological Signalling Studies (Cluster of Excellence, http://www.bioss.uni-freiburg.de). Positions are available from January 2012. For more information, please visit the lab web site (http://www.biochemie.uni-freiburg.de/hunte/, go to « Research ») or contact Carola Hunte, to whom applications should be sent by Email. ------------------------------------------------------------------------------------------------------------------------------------------------------------ Prof. Dr. Carola Hunte, Institute for Biochemistry and Molecular Biology, BIOSS Centre for Biological Signalling Studies, University of Freiburg, Germany (http://www.biochemie.uni-freiburg.de/hunte/)
